Details of the Drug Reposition

General Information of This Drug (ID: DMH8IT5)

Drug Name
Donaperminogene seltoplasmid   DMH8IT5
Synonyms VM202
Drug Type
Gene therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Diabetic neuropathy DISX6VF8 8C0Z Phase 3 [1]
Diabetic foot ulcer DISXVPHM BD54 Phase 3 [2]
------------------------------------------------------------------------------------
1 Phase 1/2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Amyotrophic lateral sclerosis DISF7HVM 8B60.0 Phase 1/2 [3]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT02427464) Phase 3 Gene Therapy for Painful Diabetic Neuropathy. U.S. National Institutes of Health.
2 ClinicalTrials.gov (NCT02563522) Safety and Efficacy Study of VM202 in the Treatment of Chronic Non-Healing Foot Ulcers. U.S. National Institutes of Health.
3 ClinicalTrials.gov (NCT02039401) Safety Study of VM202 to Treat Amyotrophic Lateral Sclerosis. U.S. National Institutes of Health.